US FDA Form 483 inspection letters no cause for panic
This article was originally published in RAJ Devices
Executive Summary
A post-inspection letter from the US Food and Drug Administration raising concerns about a device company’s facilities may be unwelcome, but it could also be seen as an opportunity, according to one expert.